课题基金 / 基金详情

Nebraska Center for Molecular Target Discovery and Development

Nebraska Center for Molecular Target Discovery and Development
内布拉斯加州分子靶标发现和开发中心
批准号:
10392932
负责人:
Robert E. Lewis
金额:
$227.02万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-03-16 至 2023-07-19

项目摘要

项目成果

Robert E. Lewis的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要:总体中心组织和管理计划 内布拉斯加州分子靶标发现和开发中心的目标是建立和扩大 内布拉斯加大学医学中心(UNMC)和内布拉斯加大学的体力和智力资源 内布拉斯加州系统,将催化其教职员工定义、验证和开发潜在疗法的能力 针对临床重要疾病的分子靶点。该中心的目标是使双方的投资最大化 科布尔奖和UNMC加强研究所的研究能力,扩大翻译 其教师的能力,促进有前途的初级教师在有针对性的领域的职业发展 治疗,并有效地推动发现和发展,以改善人类健康 内布拉斯加州和整个国家。该中心将(1)创建关键基础架构,用于发现和验证 对疾病发展至关重要的分子效应器以及(2)为有希望的人提供培训和指导 新的研究人员愿意并能够利用这一基础设施来验证这些效应器是否为治疗目标, 确定用于其操作的小分子,并为其创建体外和体内的临床前模型 开发作为新的治疗方法。中心调查人员带来了必要的尖端专业知识 实现这一愿景。他们都有一个共同的信念,即许多疾病可以有效地分类和 通过详细的基因组、遗传和分子分析来确定驱动因素和漏洞 从中将出现独特的治疗方法。为了实现这一共同愿景,该中心及其 调查人员将:1)建立行政核心和指导计划,以支持和加强 目标发现和开发方面的研究;2)建立一支专注于 确定、确认和开发疾病治疗的治疗目标;以及3)增加 通过高通量化学、RNAi和计算机筛选的科学核心进行研究的能力; 质谱学;和目标验证。
英文摘要
Project Summary/Abstract: Overall Center Organization and Management Plan The goal of the Nebraska Center for Molecular Target Discovery and Development is to establish and expand physical and intellectual resources at the University of Nebraska Medical Center (UNMC) and the University of Nebraska system that will catalyze the ability of its faculty to define, validate, and develop potential therapies against molecular targets for clinically important diseases. The Center aims to maximize investment from both the COBRE award and UNMC to enhance the research capabilities of the Institution, expand the translational capabilities of its faculty, facilitate career advancement of promising junior faculty in the area of targeted therapeutics, and efficiently drive discovery and development for the improvement of human health in Nebraska and the nation. This Center will (1) create critical infrastructure for the discovery and validation of molecular effectors critical to the development of disease and (2) deliver training and mentoring to promising new investigators willing and able to use that infrastructure to validate those effectors as therapeutic targets, identify small molecules for their manipulation, and create in vitro and in vivo preclinical models for their development as novel therapies. Center investigators bring a breadth of cutting edge expertise necessary to accomplish this vision. They share a common belief that many diseases can be effectively classified and characterized through detailed genomic, genetic, and molecular analyses to identify drivers and vulnerabilities from which will emerge unique therapeutic approaches. To realize this shared vision, the Center and its investigators will: 1) Establish an Administrative Core and mentoring programs to support and enhance research in target discovery and development; 2) Establish a critical mass of investigators focused on the identification, validation and development of therapeutic targets for disease treatment; and 3) Increase research capacity through scientific cores for high throughput chemical, RNAi and computational screening; mass spectrometry; and target validation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pancreatic cancer variant analysis of the All of Us cohort
Novel Mechanisms Controlling SCLC Tumor Initiation
Novel Mechanisms Controlling SCLC Tumor Initiation
Nebraska Center for Molecular Target Discovery and Development
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: